vs
Side-by-side financial comparison of Edwards Lifesciences (EW) and TFI International Inc. (TFII). Click either name above to swap in a different company.
Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $921.9M, roughly 1.8× TFI International Inc.).
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
TFI International Inc. is a Canadian transport and logistics company based in Saint-Laurent, Quebec, a borough of Montreal. It operates primarily in Canada, the United States, and Mexico through 4 business segments: less than truckload (LTL), package and courier, logistics, and truckload. It has Canada's largest LTL business, largest trucking fleet, and in 2021 was ranked 6th in terms of revenue among both LTL and truckload North American carriers. Its trucking fleet consists of over 14,000 c...
EW vs TFII — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $921.9M |
| Net Profit | $380.7M | — |
| Gross Margin | 78.0% | — |
| Operating Margin | 1.8% | 8.4% |
| Net Margin | 23.1% | — |
| Revenue YoY | 16.7% | — |
| Net Profit YoY | 6.8% | — |
| EPS (diluted) | $0.66 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | $921.9M | ||
| Q2 25 | $1.5B | $2.0B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.4B | $2.3B |
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | — | ||
| Q3 25 | $291.1M | — | ||
| Q2 25 | $333.2M | $98.2M | ||
| Q1 25 | $358.0M | $56.0M | ||
| Q4 24 | $385.6M | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $366.3M | $117.8M |
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | — | ||
| Q3 25 | 19.8% | 8.4% | ||
| Q2 25 | 26.8% | 8.4% | ||
| Q1 25 | 27.9% | 5.8% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 25.9% | 9.5% | ||
| Q2 24 | 26.8% | 9.2% |
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 21.7% | 4.8% | ||
| Q1 25 | 25.3% | 2.9% | ||
| Q4 24 | 27.8% | — | ||
| Q3 24 | 226.7% | — | ||
| Q2 24 | 26.7% | 5.2% |
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | — | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.56 | — | ||
| Q1 25 | $0.61 | — | ||
| Q4 24 | $0.65 | — | ||
| Q3 24 | $5.13 | — | ||
| Q2 24 | $0.61 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
